The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer

The prognostic value of C-reactive protein, compared with ECOG performance status (ECOG-ps), in patients receiving alpha-interferon treatment for advanced renal cancer was assessed in 58 patients. In all, 55 patients died on follow-up. On multivariate analysis with ECOG-ps and C-reactive protein ent...

Descripción completa

Detalles Bibliográficos
Autores principales: Bromwich, E, McMillan, D C, Lamb, G W A, Vasey, P A, Aitchison, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409897/
https://www.ncbi.nlm.nih.gov/pubmed/15354220
http://dx.doi.org/10.1038/sj.bjc.6602152
_version_ 1782155892768112640
author Bromwich, E
McMillan, D C
Lamb, G W A
Vasey, P A
Aitchison, M
author_facet Bromwich, E
McMillan, D C
Lamb, G W A
Vasey, P A
Aitchison, M
author_sort Bromwich, E
collection PubMed
description The prognostic value of C-reactive protein, compared with ECOG performance status (ECOG-ps), in patients receiving alpha-interferon treatment for advanced renal cancer was assessed in 58 patients. In all, 55 patients died on follow-up. On multivariate analysis with ECOG-ps and C-reactive protein entered as covariates, only C-reactive protein was a significant independent predictor of survival (HR 2.03, 95% CI 1.09–3.80, P=0.026).
format Text
id pubmed-2409897
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-24098972009-09-10 The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer Bromwich, E McMillan, D C Lamb, G W A Vasey, P A Aitchison, M Br J Cancer Clinical The prognostic value of C-reactive protein, compared with ECOG performance status (ECOG-ps), in patients receiving alpha-interferon treatment for advanced renal cancer was assessed in 58 patients. In all, 55 patients died on follow-up. On multivariate analysis with ECOG-ps and C-reactive protein entered as covariates, only C-reactive protein was a significant independent predictor of survival (HR 2.03, 95% CI 1.09–3.80, P=0.026). Nature Publishing Group 2004-10-04 2004-08-31 /pmc/articles/PMC2409897/ /pubmed/15354220 http://dx.doi.org/10.1038/sj.bjc.6602152 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical
Bromwich, E
McMillan, D C
Lamb, G W A
Vasey, P A
Aitchison, M
The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer
title The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer
title_full The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer
title_fullStr The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer
title_full_unstemmed The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer
title_short The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer
title_sort systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409897/
https://www.ncbi.nlm.nih.gov/pubmed/15354220
http://dx.doi.org/10.1038/sj.bjc.6602152
work_keys_str_mv AT bromwiche thesystemicinflammatoryresponseperformancestatusandsurvivalinpatientsundergoingalphainterferontreatmentforadvancedrenalcancer
AT mcmillandc thesystemicinflammatoryresponseperformancestatusandsurvivalinpatientsundergoingalphainterferontreatmentforadvancedrenalcancer
AT lambgwa thesystemicinflammatoryresponseperformancestatusandsurvivalinpatientsundergoingalphainterferontreatmentforadvancedrenalcancer
AT vaseypa thesystemicinflammatoryresponseperformancestatusandsurvivalinpatientsundergoingalphainterferontreatmentforadvancedrenalcancer
AT aitchisonm thesystemicinflammatoryresponseperformancestatusandsurvivalinpatientsundergoingalphainterferontreatmentforadvancedrenalcancer
AT bromwiche systemicinflammatoryresponseperformancestatusandsurvivalinpatientsundergoingalphainterferontreatmentforadvancedrenalcancer
AT mcmillandc systemicinflammatoryresponseperformancestatusandsurvivalinpatientsundergoingalphainterferontreatmentforadvancedrenalcancer
AT lambgwa systemicinflammatoryresponseperformancestatusandsurvivalinpatientsundergoingalphainterferontreatmentforadvancedrenalcancer
AT vaseypa systemicinflammatoryresponseperformancestatusandsurvivalinpatientsundergoingalphainterferontreatmentforadvancedrenalcancer
AT aitchisonm systemicinflammatoryresponseperformancestatusandsurvivalinpatientsundergoingalphainterferontreatmentforadvancedrenalcancer

Ejemplares similares